首页 >
法规速递
-
国家药监局综合司公开征求《关于药品注册申请实施电子申报的公告（征求意见稿）》等文件意见-2022/11/4
2022-11-30查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第七十一批）》（征求意见稿）意见的通知-2023/6/9
2023-06-12查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第七十七批）》（征求意见稿）意见的通知-2023/12/7
2023-12-21查看详情 > -
Document: Innovation Task Force (ITF) briefing meeting request form-2025/1/22
2025-01-23查看详情 > -
Document: Agenda of the CHMP meeting 24-27 February 2025-2025/2/2/4
2025-02-25查看详情 > -
Document: Minutes of the CAT meeting 19-21 February 2025-2025/4/1
2025-04-02查看详情 > -
国家药监局关于发布免于进行临床评价医疗器械目录的通告（2025年第19号）-2025/5/13
2025-05-14查看详情 > -
Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23-2025/6/19
2025-06-20查看详情 > -
Page: Safety and residue data requirements for the establishment of maximum residue limits in minor species - Scientific guideline-2025/7/24
2025-07-25查看详情 > -
Document: Portfolio and technology meeting briefing document-2025/9/9
2025-09-10查看详情 >
